Preconditioning: we do not need more experiments, because our current knowledge already permits us to develop pharmacological agents.
Opie
L H
LH
Ischaemic Heart Disease Research Unit of the Medical Research Council, University of Cape Town Medical School, South Africa.
D000241:Adenosine / Q000494:pharmacology*; D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism; D002317:Cardiovascular Agents / Q000494:pharmacology*; D000242:Cyclic AMP / Q000096:biosynthesis; D005609:Free Radicals / Q000378:metabolism; D006801:Humans; D019157:Ischemic Preconditioning, Myocardial / Q000379:methods; D008564:Membrane Potentials / Q000187:drug effects; D015428:Myocardial Reperfusion Injury / Q000378:metabolism / Q000517:prevention & control*; D015221:Potassium Channels / Q000187:drug effects / Q000378:metabolism; D011493:Protein Kinase C / Q000187:drug effects / Q000378:metabolism
D002121:Calcium Channel Blockers; D015220:Calcium Channels; D002317:Cardiovascular Agents; D005609:Free Radicals; D015221:Potassium Channels; D000242:Cyclic AMP; D011493:Protein Kinase C; D000241:Adenosine